iQflow Receives MFDS Approval for Insulin Injection Control App
[Asia Economy Reporter Seo Sojeong] IoFlow announced on the 24th that it has received medical device approval from the Ministry of Food and Drug Safety for its smartphone application 'Narsya'.
Narsya is a smartphone-exclusive app that monitors the device status of IoFlow's wearable insulin pump, 'IoPatch', in real time and controls insulin infusion. It is the world's first app capable of insulin infusion control.
It features the ability to check blood glucose data in real time by linking with a separate continuous glucose monitor (CGM).
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
It can be linked with Huons' 'Dexcom G6' sensor.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
